Cargando…
Human Wharton’s Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562 in vitro by Inducing Cell Cycle Arrest and Apoptosis
Emerging resistance to the tyrosine kinase inhibitors that target the BCR-ABL1 oncoprotein has prompted research for novel therapeutics against chronic myeloid leukemia (CML). Herein, we evaluated the tumor inhibitory properties of the human Wharton’s jelly stem cells (hWJSCs) co-culture (hWJSC-CC)...
Autores principales: | Huwaikem, Muneerah A. H., Kalamegam, Gauthaman, Alrefaei, Ghadeer, Ahmed, Farid, Kadam, Roaa, Qadah, Talal, Sait, Khalid H. W., Pushparaj, Peter N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044948/ https://www.ncbi.nlm.nih.gov/pubmed/33869169 http://dx.doi.org/10.3389/fcell.2021.614988 |
Ejemplares similares
-
Cytokines secreted by human Wharton's jelly stem cells inhibit the proliferation of ovarian cancer (OVCAR3) cells in vitro
por: Kalamegam, Gauthaman, et al.
Publicado: (2019) -
Human Wharton's Jelly Stem Cell (hWJSC) Extracts Inhibit Ovarian Cancer Cell Lines OVCAR3 and SKOV3 in vitro by Inducing Cell Cycle Arrest and Apoptosis
por: Kalamegam, Gauthaman, et al.
Publicado: (2018) -
Corrigendum: Human Wharton’s Jelly stem cell (hWJSC) extracts inhibit ovarian cancer cell lines OVCAR3 and SKOV3 in vitro by inducing cell cycle arrest and apoptosis
por: Kalamegam, Gauthaman, et al.
Publicado: (2023) -
Primary ovarian cancer cell inhibition by human Wharton's Jelly stem cells (hWJSCs): Mapping probable mechanisms and targets using systems oncology
por: Kalamegam, Gauthaman, et al.
Publicado: (2015) -
Unraveling the Catha edulis Extract Effects on the Cellular and Molecular Signaling in SKOV3 Cells
por: Abou-Elhamd, Alaa Sayed, et al.
Publicado: (2021)